Perfil
Andrew Young is the founder of Satiogen Pharmaceuticals, Inc. (founded in 2007) and Phoundry Pharmaceuticals, Inc. (founded in 2015, where he also holds the title of Director & Chief Scientific Officer).
He previously worked as Vice President-Research at Amylin Pharmaceuticals, Inc., as a Professor-Physiology Department at Auckland University, and as a Clinical Research Scientist at the National Institutes of Health from 1984 to 1987.
Dr. Young received his graduate and doctorate degrees from Auckland University.
Cargos activos de Andrew Young
| Empresas | Cargo | Inicio |
|---|---|---|
Phoundry Pharmaceuticals, Inc.
Phoundry Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the discovery of peptide therapeutics | Fundador | 01/01/2015 |
Antiguos cargos conocidos de Andrew Young.
| Empresas | Cargo | Fin |
|---|---|---|
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Director Técnico/Científico/I+D | 01/01/1987 |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Fundador | - |
Auckland University
Auckland University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Director Técnico/Científico/I+D | - |
Formación de Andrew Young.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Auckland University
Auckland University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Commercial Services |
Phoundry Pharmaceuticals, Inc.
Phoundry Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the discovery of peptide therapeutics | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Young
















